Category: Department of Infectious Disease

From Virology Master’s student to COVID-19 testing team leader

Recent graduate Samuel Badru is part of the lab team analysing samples for Imperial’s in-house Covid-19 testing scheme  – here he shares the steps to processing a successful test.


I would have never guessed that five months into studying a Master’s in Molecular Biology and Pathology of Viruses, the world would be stopped in its track on account of a virus. Lockdown descended on the nation two weeks into my project, which for me meant more bioinformatics from home and no more laboratory work. Little did I know that I would return to St Mary’s Campus’ laboratories to assist in the effort to combat the COVID-19 pandemic!

I joined the College’s in-house SARS-Cov-2 testing team in October 2020 – the day after my results day (which went well!). There are a number of steps to the testing workflow that definitely seemed overwhelming at first, but after more than two months in it is all pretty much second nature. (more…)

A letter to our taught students and their loved ones

This is an open letter from Mr Martin Lupton, Vice-Dean of Education to taught students in the Faculty of Medicine and their loved-ones.


Dear Students and their friends and families,

My eldest son has recently returned to University in the UK and, even though I work in both the health and education sector, I have to acknowledge that I have a certain level of anxiety about him. It is very difficult to read the news about all that has happened during this time of COVID and not to worry.

I am telling you this because I want you to understand that I have some inkling of what you may be feeling right now, particularly if you come from overseas or your daughter, son or relation, has just started their university life. The first thing I want to say is “Welcome to the Faculty of Medicine”. We are very proud of what we have achieved during this global pandemic; the Faculty of Medicine at Imperial College has been a key player contributing to the world’s understanding of the virus, the mapping of the virus, teaching people about the virus and developing a new vaccine. However, that is not all that we have been doing. (more…)

‘We answered the call to volunteer at the Lighthouse ‘mega-lab’ for COVID-19 testing’

The team of volunteers celebrating reaching 1 million samples tested. (Image credit: UK Biocentre)

Four Imperial researchers recount their experiences of volunteering at one of the mega-labs built to scale up COVID-19 testing in the UK.


Since March, the UK Biocentre laboratories located in Milton Keynes has become one of four Lighthouse Labs (the others are in Glasgow, Alderley Park in Cheshire and Cambridge) – the largest network of diagnostic testing facilities in British history. Every day the team process and analyse around 30,000 swab samples from across the country to test for the presence of the SARS-CoV-2 virus that causes COVID-19. They use a combination of manual processing and high-throughput robots to inactivate the viral samples, extract the RNA and analyse them with a technique known as quantitative polymerase chain reaction (qPCR) to detect the presence of the virus.

The UK Biocentre labs were uniquely placed to help in the testing efforts, as in normal life they are usually home to around 30 staff processing and archiving clinical samples from hospitals around the UK. 200 volunteers across academia, civil service and industry answered a call to support with COVID-19 testing, including several PhD students and postdocs from Imperial. As their secondments draw to a close, we speak to some of the volunteers to hear about their experience: (more…)

My experience of lockdown and maternity as a female academic

Dr Teresa Thurston shares her experience as a relatively new PI of looking after a new-born, homeschooling and keeping in touch with her lab during lockdown.


The pressure of the pandemic has been felt particularly hard by parents juggling work and childcare, often with fewer hours available for work. In some households, the burden of care work continues to fall disproportionately on women and this may be true for academia as well; journal editors have noted that early evidence suggests fewer paper submissions from women than men whilst under quarantine.

Every one of us has been hit by lockdown and many people are struggling to juggle work with kids at home. It has been more than 50 days since my family of five begun isolation. My husband came down with a fever and cough and went to bed and I picked up the kids for the last time. After telling our afterschool nanny not to come over, panic hit. I had no idea how I was going to cope. I was still recovering from delivering a 5Kg baby who was just four weeks old and now I was solely responsible for three kids and a sick husband. This was not going to be any ordinary maternity leave. (more…)

Being a caregiver while caring about a PhD

Republished by permission from Springer Nature: Nature Career Column, Being a caregiver while caring about a PhD, Luke Yates, © 2020

Luke Yates discusses how he coped with his wife’s long illness during his PhD programme.


In summer 2008, a year after I started my PhD programme, my wife Samantha was admitted to hospital with a severe chest infection. Sam had cystic fibrosis, and the infection wreaked havoc on her lungs. After a protracted hospitalization, she could not breathe unaided. Furnished with a canister of oxygen and breathing apparatus (a mainstay from then on), along with a substantial amount of antibiotics and other medications, she left hospital, and we carried on with our lives as best as we could. Sam went back to her job teaching a school class of 9–10-year-olds, and I continued pursuing my PhD in clinical medicine at the University of Oxford, UK. But she experienced another infection, which ended with her doctors wait-listing her for a double lung transplant. In January 2010, Sam gave up work, and we began to hope for a life-saving telephone call.

Caring for a loved one who had cystic fibrosis and was waiting for a transplant, while I was trying to complete my PhD programme, seemed impossible. In the laboratory, I was always on tenterhooks, thinking “Today could be the day we get the call.” This uncertainty and anxiety, together with the pressures of research, made my graduate studies tougher than most. As for planning my experiments and conducting research, I needed limited working hours so that I could provide physiotherapy, drug treatments and help to my wife. And I had to get home at a specific time because I shared caregiving responsibilities with Sam’s mum, who tended to her during the day. On top of all this, I had a daily commute of more than two hours. We couldn’t move closer, because we needed to live near our family. (more…)

What is the new coronavirus (2019-nCoV) and what do we know about the outbreak so far?

This post was last updated on 31 January 2020

What is the ‘Wuhan coronavirus (2019-nCoV)’ and what do we know about it so far?
Dr John Tregoning (JT) from Imperial’s Department of Infectious Disease spoke to the School of Public Health’s Prof Steven Riley (SR) about the coronavirus outbreak that recently began in Wuhan, China.


Who has been working on the outbreak epidemiology at Imperial College London?

SR: I work as part of the MRC Centre for Global Infectious Disease  Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics centre with Prof Neil Ferguson, Dr Natsuko Imai, Dr Ilaria Dorigatti, Dr Anne Cori Prof Christl Donnelly, Prof Azra Ghani and Dr Marc Baguelin.

So what is this new coronavirus?

SR: It is a viral infection that was first discovered in the Chinese city of Wuhan in 2019 that has been associated with a number of cases of pneumonia – an infection of the tissue in the lungs. You might see it being called ‘2019-nCoV’, which stand for novel (or new) coronavirus. More information has been provided by the World Health Organisation. (more…)

Alive and ticking: Is Lyme disease on the rise in the UK?

Lyme disease UK

Justin Bieber’s recent Lyme disease diagnosis has brought the disease into the public eye. Professor Gareth Tudor-Williams explores whether there is a link between tick behaviour and a rise in reported cases.


It’s a fact that every time a high profile individual reveals that they have Lyme disease – the latest being singer Justin Bieber – there is an appreciable spike in internet searches, followed a short while later by an increase in the number of blood samples being sent for testing to the Public Health England national reference laboratory at Porton Down.

So this trend would suggest that the publicity about Lyme disease increases health-seeking behaviour in this country, which in turn leads to more cases being diagnosed.

All of which begs several questions. Is the incidence truly rising or are more people being diagnosed who would not previously have been tested? Are there significant numbers of people living in the UK with undiagnosed and therefore untreated infection?  What proportion of untreated infected individuals develop long-term health problems? (more…)

Governments need scientists to shape a brighter, evidence-based future

Dr Julia Makinde
This festive period Three Wise Women from the Faculty of Medicine will be giving us the gift of wisdom.

Our second is Dr Julia Makinde, an HIV researcher at the IAVI Human Immunology Lab, who makes the case for translating science into policy.


A dearth of advisers

A section of the nativity story portrays Herod the Great as something of a tyrant. A man who sanctioned an order to wipe out every male infant born in and around Bethlehem in a pre-emptive action to eliminate the threat of a new-born king. As difficult as it is to imagine anyone, let alone a political leader, endorsing the massacre of innocent children, the story presents an interesting metaphor of complex political motivations and the outcome of a breakdown in the process of policy making.

With vaccinations, climate change and access to healthcare taking centre stage in the global debate, the intersection between science and policy has never been more relevant. Whilst I started out in research with the desire to help create solutions to global healthcare challenges, I have come to understand that the actions taken to disseminate research outcomes are just as important as the process of discovery itself. (more…)

My mental health and academia: an open letter

mental health academia

As part of UK Disability History Month, Dr Catherine Kibirige reflects on her mental health journey and how she’s using her experiences to help others.


My name is Dr Catherine Kibirige and I’m a Research Associate at Imperial, based at the Chelsea and Westminster Hospital.  

I have a mental health disability. It’s been a difficult journey accepting this, and this is the first time I’ve publicly disclosed it. For a long time, I didn’t want to believe that I had a “mental illness”, or that I was disabled. The funny thing is, once I accepted these things, it’s allowed me to do better and to feel more capable than I have done before. Here in the UK, we’re currently celebrating Disability History Month. In celebration of this, I wanted to share my story and how the College has helped and supported me.     (more…)

HTLV-1: Time to care, time to take action

HTLV-1

Ahead of the WHO Global Consultation on HTLV-1, Professor Graham Taylor outlines three steps to prioritise the neglected cancer-causing virus.


“I couldn’t do anything for a week after I opened the letter and saw that I was infected with it. I saw H and thought I had HIV. I’d never heard of HTLV”.

It’s not the first time that I’ve heard this, but this was two days ago, almost 40 years since the report in 1980 of the discovery of the human T-cell lymphotropic virus (HTLV-1). Sadly Janet* is joined in her lack of awareness not only by almost the entire general public but also by most healthcare professionals.

This weekend saw World HTLV Day marked for the second year, with the slogan is: ‘It’s time to care’. This is in response to a general perception that there is a widespread indifference toward HTLV. Hopefully this will change soon. This week, I fly to Tokyo to participate in a WHO Global Consultation on HTLV-1 to address the public health impact and implications of this little-known virus. (more…)